Business
Sickest coronavirus patients to be treated with arthritis drugs after study finds reduction in death rates – ABC News
A study finds treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces…
A study has found treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces the amount of time patients need intensive care.
Key points:
- The study involved 800 severely ill COVID-19 patients
- The UK Government said the drugs will be used to treat critically ill COVID-19 patients
- Results showed that on average, patients treated with Actemra or Kevzara recovered more swiftly
The findings, which have not yet been…
Continue Reading
-
Noosa News22 hours agoInside the $5.4 million Clayfield home where CEO Greg Josephson was allegedly stabbed to death
-
Business23 hours agoHow you could turn $10k into $100k with ASX shares
-
Noosa News24 hours agoPolice charge teen with alleged murder of Universal Store co-founder
-
Noosa News24 hours agoIllegal explosives and firearms allegedly uncovered during DV-related raid at Walkerston in Mackay